262
Participants
Start Date
May 10, 2005
Primary Completion Date
August 25, 2008
Study Completion Date
August 25, 2008
Rituximab
Rituximab will be supplied as a sterile liquid for IV administration.
Placebo
Placebo will be supplied as a sterile liquid for IV administration.
Prednisone
Acetaminophen
Diphenhydramine
NYU-Hosp for Joint Diseases; Rheum and Med, New York
Hospital for Special Surgery, New York
Feinstein Institute for Medical Research, Manhasset
NS-LIJ Health Systems; Rheum-Allergy Clin Immu, Lake Success
SUNY Downstate Medical Center., Brooklyn
Long Island Osteo/Arth Center, Plainview
Center for Rheumatology, State Uni. of New York, Albany
Buffalo Rheumatology Associates, Orchard Park
University of Rochester - Strong Memorial Hospital, Rochester
University of Pittsburgh, Pittsburgh
Altoona Arthritis & Osteo Center, Duncansville
East Penn Rheumatology Associates, Pc, Bethlehem
Uni of Pennslyvania Medical Center, Philadelphia
Albert Einstein Medical Center, Philadelphia
Center For Rheumatology & Bone Research, Wheaton
Johns Hopkins Uni, Baltimore
University of Virginia Med Ctr; Div of Ped Respiratory Med, Charlottesville
Virginia Commonwealth University, Richmond
University of North Carolina Hospitals Department of Pharmacy; Investigational Drug Services, Chapel Hill
Duke Medical Center, Durham
Physicians East Pa, Greenville
Medical Univ of South Carolina, Charleston
Emory Uni ; Division of Rheumatology, Atlanta
Arthritis & Rheumatism; Disease Specialities, Aventura
Family Arthritis Center, Jupiter
Univ of Alabama School of Med; Clinical Immun Rheumatology, Birmingham
Rheumatology Assoc of North AL, Huntsville
Arthritis Associates PLLC, Chattanooga
Kentuckiana Cancer Institute, Louisville
Ohio State University; Division of Nephrology, Columbus
Tri-State Arth & Rheum Center, Evansville
University Of Michigan, Ann Arbor
Michigan Arthritis Rsrch Ctr, Brighton
Northwestern University, Chicago
Rheumatology Associates, Chicago
University of Chicago, Chicago
Washington University; Rheumatology Division, St Louis
Univ of Kansas Medical Center; Allergy/Clin Imm/Rheum, Kansas City
LA State Univ; Medicine, Shreveport
Bone and Joint Hospital at St. Anthony Research Department, Oklahoma City
Oklahoma Medical Research Foundation, Oklahoma City
Oklahoma Center For Arthritis Therapy & Research, Tulsa
Metroplex Clinical Research, Dallas
Arthritis Centers of Texas, Dallas
Houston Inst. For Clinical Research, Houston
Texas Research Center, Sugar Land
Arthritis & Osteoporosis Associates, LLP, Lubbock
University of Colorado Denver, Aurora
Intermountain Research Center, Boise
Coeur D'Alene Arthritis Clinic, Coeur d'Alene
Arizona Arthritis & Rheumatology Research, Pllc, Paradise Valley
Univ of Calif., Los Angeles; Rheumatology, Los Angeles
Cedars-Sinai Medical Center, Los Angeles
Univ of California, San Diego, La Jolla
Stanford University Med Ctr;Div of Immunology/Rheumatology, Palo Alto
Eden Medical Center San Leandro Hospital, San Leandro
Portland Medical Associates, Portland
Seattle Rheumatology Assoc; Swedish Rheumatology Research, Seattle
Seattle Cancer Care Alliance, Seattle
Arthritis Northwest, Spokane, Spokane
Univ of Calif, San Francisco; Rheumatology, San Francisco
Tufts - New England Medical Center, Boston
Dana-Farber Cancer Institute; Rheumatology, Boston
Univ of Manitoba, Health Scien; Arthritis Centre, Winnipeg
St. Joseph'S Health Care Centre, London
Lead Sponsor
Genentech, Inc.
INDUSTRY